Back
59
50
68
43
Day Range
$14.43
$17.35
52-Week Range
$14.07
$25.32
Volume
1
50D / 200D Avg
$16.79
/
$19.46
Prev Close
$14.43
Price History
Financial Trends
Peer Comparison
vs Consumer Cyclical sector median (610 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 5.9 | 11.1 |
| P/B | 1.6 | 1.4 |
| ROE % | 29.6 | 10.7 |
| Net Margin % | 6.2 | 5.1 |
| Rev Growth 5Y % | 106.4 | 8.1 |
| D/E | 0.7 | 0.8 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
$2.92
$2.85 – $3.02
|
9.9 B | 1 |
| FY2028 |
$2.11
$2.06 – $2.18
|
8.9 B | 1 |
| FY2027 |
$1.83
$1.79 – $1.90
|
8.3 B | 1 |
Key Takeaways
Revenue grew 106.38% annually over 5 years — strong growth
ROE of 29.58% indicates high profitability
Generating 659.10M in free cash flow
P/E of 5.92 — trading at a low valuation
PEG of 0.70 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 91.70%
Growth
Revenue Growth (5Y)
106.38%
Revenue (1Y)14.68%
Earnings (1Y)11.92%
FCF Growth (3Y)-6.60%
Quality
Return on Equity
29.58%
ROIC12.18%
Net Margin6.23%
Op. Margin6.22%
Safety
Debt / Equity
0.71
Current Ratio1.20
Interest Coverage7.70
Valuation
P/E Ratio
5.92
P/B Ratio1.64
EV/EBITDA5.82
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 14.68% | Revenue Growth (3Y) | 19.38% |
| Earnings Growth (1Y) | 11.92% | Earnings Growth (3Y) | 23.95% |
| Revenue Growth (5Y) | 106.38% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 7.17B | Net Income (TTM) | 446.80M |
| ROE | 29.58% | ROA | 7.56% |
| Gross Margin | 12.53% | Operating Margin | 6.22% |
| Net Margin | 6.23% | Free Cash Flow (TTM) | 659.10M |
| ROIC | 12.18% | FCF Growth (3Y) | -6.60% |
| Safety | |||
| Debt / Equity | 0.71 | Current Ratio | 1.20 |
| Interest Coverage | 7.70 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 5.92 | P/B Ratio | 1.64 |
| P/S Ratio | 0.37 | PEG Ratio | 0.70 |
| EV/EBITDA | 5.82 | Dividend Yield | 0.01% |
| Market Cap | 2.65B | Enterprise Value | 2.60B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7.17B | 6.26B | 5.03B | 1.23B | 395.40M |
| Net Income | 446.80M | 399.20M | 290.80M | -315.40M | -271.20M |
| EPS (Diluted) | 1.86 | 1.65 | 1.27 | -1.47 | -1.51 |
| Gross Profit | 898.70M | 841.20M | 707.70M | -147.90M | -264.90M |
| Operating Income | 446.50M | 428.20M | 394.00M | -323.90M | -336.10M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5.91B | 5.57B | 4.53B | 3.99B | 2.87B |
| Total Liabilities | 4.30B | 4.16B | 3.51B | 3.10B | 1.91B |
| Shareholders' Equity | 1.61B | 1.41B | 1.01B | 896.60M | 964.20M |
| Total Debt | 1.14B | 1.46B | 1.38B | 1.57B | 1.32B |
| Cash & Equivalents | 1.19B | 1.44B | 955.20M | 1.05B | 1.38B |
| Current Assets | 3.71B | 3.67B | 2.99B | 2.61B | 1.54B |
| Current Liabilities | 3.08B | 2.70B | 2.26B | 1.68B | 858.20M |
Strategy Scores
This stock passed the criteria for 4 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#240 of 1052
#179 of 618
#58 of 670
Custom
Lower Risk
#85 of 140
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026
Entered
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026
Entered
Lower Risk
Mar 24, 2026